Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2024 Feb 25;196(7):E235-E240.
doi: 10.1503/cmaj.230356.

Advances in the management of renal cell carcinoma

Luisa M Cardenas  1 , Samantha Sigurdson  1 , Christopher J D Wallis  1 , Aly-Khan Lalani  2 , Anand Swaminath  2
Affiliations
Review

Advances in the management of renal cell carcinoma

Luisa M Cardenas et al. CMAJ. .

Erratum in

No abstract available

PubMed Disclaimer

Conflict of interest statement

Competing interests: Christopher Wallis has received consulting fees from Janssen Oncology, Nanostics, Inc., Precision Point Specialty LLC, Sesen Bio; honoraria or travel fees from AbbVie, Astellas, AstraZeneca, Bayer, EMD Serono, Haymarket Media, Healing and Cancer Foundation, Janssen, Knight Therapeutics, Merck, Science & Medicine Canada, TerSera Canada, and Tolmar Pharmaceuticals Canada; research funding from Knight Therapeutics, Tolmar Pharmaceuticals and Bayer. Aly-Khan Lalani has received honoraria and/or consultancy fees from AbbVie, Astellas Pharma, Bayer, Bristol Myers Squibb, Eisai, Ipsen, Janssen, Merck, Novartis, Pfizer, Roche/Genentech and TerSera, and research funding from Bristol Myers Squibb, BioCanRx, EMD Serono, Ipsen, Novartis and Roche. Anand Swaminath has received honoraria from Bristol Myers Squibb, Eisai, and AstraZeneca, and holds a voluntary position on the medical advisory board for Kidney Cancer Canada.

References

    1. Brenner DR, Poirier A, Woods RR, et al. . Projected estimates of cancer in Canada in 2022. CMAJ 2022;194:E601–7. - PMC - PubMed
    1. Bukavina L, Bensalah K, Bray F, et al. . Epidemiology of renal cell carcinoma: 2022 update. Eur Urol 2022;82:529–42. - PubMed
    1. Wah TM, Irving HC, Gregory W, et al. . Radiofrequency ablation (RFA) of renal cell carcinoma (RCC): experience in 200 tumours. BJU Int 2014;113:416–28. - PMC - PubMed
    1. Motzer RJ, McDermott DF, Escudier B, et al. . Conditional survival and long-term efficacy with nivolumab plus ipilimumab versus sunitinib in patients with advanced renal cell carcinoma. Cancer 2022;128:2085–97. - PMC - PubMed
    1. Richard PO, Violette PD, Bhindi B, et al. . Canadian Urological Association guideline: Management of small renal masses: full text. Can Urol Assoc J 2022; 16: E61–75. - PMC - PubMed